Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHEOPS: Vinorelbine +/- Aromatase Inhibitor in Pretreated Metastatic Breast Cancer
NCT02585388Phase 2Terminated
- Sponsor
- ARCAGY
- Start
- Oct 2015
- Primary completion
- May 2017
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole, anastrozole in breast cancer, sponsored by ARCAGY. Started Oct 2015; status: terminated.
02
Drugs
letrozoleanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02585388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02585388.